Acasti Pharma Stock Probability of Future Stock Price Finishing Over 2.73
| ACST Stock | USD 2.73 0.03 1.11% |
Acasti |
Acasti Pharma Target Price Odds to finish over 2.73
The tendency of Acasti Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.73 | 90 days | 2.73 | about 89.58 |
Based on a normal probability distribution, the odds of Acasti Pharma to move above the current price in 90 days from now is about 89.58 (This Acasti Pharma probability density function shows the probability of Acasti Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Acasti Pharma has a beta of -0.0857. This suggests as returns on the benchmark increase, returns on holding Acasti Pharma are expected to decrease at a much lower rate. During a bear market, however, Acasti Pharma is likely to outperform the market. Additionally Acasti Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Acasti Pharma Price Density |
| Price |
Predictive Modules for Acasti Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acasti Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acasti Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acasti Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Acasti Pharma is not an exception. The market had few large corrections towards the Acasti Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Acasti Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Acasti Pharma within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.31 | |
β | Beta against NYSE Composite | -0.09 | |
σ | Overall volatility | 0.31 | |
Ir | Information ratio | -0.16 |
Acasti Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acasti Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acasti Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Acasti Pharma generated a negative expected return over the last 90 days | |
| Net Loss for the year was (42.43 M) with profit before overhead, payroll, taxes, and interest of 120 K. | |
| Acasti Pharma currently holds about 38.39 M in cash with (15.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86. | |
| Roughly 16.0% of the company shares are held by company insiders | |
| Latest headline from benzinga.com: Acasti Pharma to Attend BIO International Convention 2024 |
Acasti Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acasti Stock often depends not only on the future outlook of the current and potential Acasti Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acasti Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.4 M | |
| Cash And Short Term Investments | 27.9 M |
Acasti Pharma Technical Analysis
Acasti Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Acasti Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acasti Pharma. In general, you should focus on analyzing Acasti Stock price patterns and their correlations with different microeconomic environments and drivers.
Acasti Pharma Predictive Forecast Models
Acasti Pharma's time-series forecasting models is one of many Acasti Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Acasti Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Acasti Pharma
Checking the ongoing alerts about Acasti Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acasti Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Acasti Pharma generated a negative expected return over the last 90 days | |
| Net Loss for the year was (42.43 M) with profit before overhead, payroll, taxes, and interest of 120 K. | |
| Acasti Pharma currently holds about 38.39 M in cash with (15.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86. | |
| Roughly 16.0% of the company shares are held by company insiders | |
| Latest headline from benzinga.com: Acasti Pharma to Attend BIO International Convention 2024 |
Check out Acasti Pharma Backtesting, Acasti Pharma Valuation, Acasti Pharma Correlation, Acasti Pharma Hype Analysis, Acasti Pharma Volatility, Acasti Pharma History as well as Acasti Pharma Performance. For more information on how to buy Acasti Stock please use our How to Invest in Acasti Pharma guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Acasti Stock analysis
When running Acasti Pharma's price analysis, check to measure Acasti Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acasti Pharma is operating at the current time. Most of Acasti Pharma's value examination focuses on studying past and present price action to predict the probability of Acasti Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acasti Pharma's price. Additionally, you may evaluate how the addition of Acasti Pharma to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Acasti Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acasti Pharma. If investors know Acasti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acasti Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.68) | Revenue Per Share 0.005 | Return On Assets (0.08) | Return On Equity (0.48) |
The market value of Acasti Pharma is measured differently than its book value, which is the value of Acasti that is recorded on the company's balance sheet. Investors also form their own opinion of Acasti Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acasti Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acasti Pharma's market value can be influenced by many factors that don't directly affect Acasti Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acasti Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acasti Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acasti Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.